Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Basal Insulin Analog and Insulin Analog Mid Mixture AS Starter Insulin for Chinese Patients With Type 2 Diabetes Mellitus (CLASSIC Study)

NCT03018938 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT03018938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03018938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Basal Insulin Analog and Insulin Analog Mid Mixture AS Starter Insulin for Chinese Patients With Type 2 Diabetes Mellitus (CLASSIC Study)
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
February 6, 2017
Completion date
July 12, 2019
Enrollment
814 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus